| Document |
Document Title |
|
WO/2011/058963A1 |
Disclosed is a noxious organism control agent which can be synthesized advantageously on an industrial scale, has an excellent biological activity and excellent residual efficacy, and has a novel skeleton. Specifically disclosed are: a 1...
|
|
WO/2011/053948A1 |
The present invention relates to compounds of the formula (I) wherein A, Y, Z, R20 to R22 and R50 have the meanings indicated in the claims, which are valuable pharmaceutical active compounds. Specifically, they are inhibitors of the end...
|
|
WO/2011/047432A1 |
The present invention relates to arylcarbonyl and heteroarylcarbonyl anthranilate compounds that may be useful as anti-fibrotic agents. The present invention also relates to methods for their preparation, pharmaceutical compositions cont...
|
|
WO/2011/045478A1 |
The present invention relates to substrates coated with films including compounds having the following generic formula (I): formula (I) as well as the manufacturing method thereof and the use of same as an anode interfacial layer in elec...
|
|
WO/2011/030645A1 |
Disclosed is a photopolymerizable composition which contains (A) a photopolymerization initiator that has a partial structure represented by general formula (1) and (B) a polymerizable compound. In general formula (1), R3 and R4 each ind...
|
|
WO/2011/023667A1 |
The present invention relates to the use of a compound of general formula (I) wherein R1/R2 are independently from each other hydrogen, lower alkyl, -CH2)o-cycloalkyl for o being 0 or 1, or are benzyl or heterocycloalkyl; or R1 and R2 ar...
|
|
WO/2011/021864A2 |
Provided is a novel xanthone derivative compound or a pharmaceutically acceptable salt of the same. The compound of the present invention or the salt of the same is useful as a chemosensitizer which reduces resistance to anticancer drugs.
|
|
WO/2010/142650A1 |
The invention relates to compounds of formula (I) wherein A1, R1, R2, R3, R4 and R5 are defined in the description and in the claims, which are preferential inhibitors of the cysteine protease cathepsin, in particular of the cysteine pro...
|
|
WO/2010/137620A1 |
Disclosed is a phenoxyethylamine derivative having an excellent selective α1D adrenergic receptor antagonistic activity. Specifically disclosed is a compound represented by formula (I) [wherein each symbol is as defined in the descripti...
|
|
WO/2010/124950A1 |
The present invention is related to novel photoinitiators, in particular to photoinitiators comprising amino groups within the molecule.
|
|
WO/2010/121487A1 |
Novel antibiotic and anticancer compounds of formulas I, II, III, IV, derivatives, ostereoisomers, the racemic or nonracemic mixture of the stereoisomers, or the pharmaceutically acceptable salts or solvates of these compounds are disclo...
|
|
WO/2010/119990A1 |
A pharmaceutical composition comprising a combination of (A) a 1-thio-D-glucitol compound represented by the general formula (I) and (B) at least one member of the group consisting of biguanides, insulin secretagogues, insulin sensitizer...
|
|
WO/2010/103297A2 |
There is provided compounds of formula (I), wherein Y, ring A1 D1, D2a, D2b, D3, L1, Y1, L3 and Y3 have meanings given in the description, and pharmaceutically-acceptable salts thereof, which compounds are useful in the treatment of dise...
|
|
WO/2010/103279A1 |
There is provided compounds of formula I, wherein Y, ring A, Da, Db, D2, D3, L1, Y1, L2, Y2, L3 and Y3 have meanings given in the description, and pharmaceutically-acceptable salts thereof, which compounds are useful in the treatment of ...
|
|
WO/2010/095390A1 |
Provided is a photosensitive resin composition which is efficiently activated by light having a wavelength of from 350 nm to 500 nm and has excellent thick-film curability and deep curability. The photosensitive resin composition contai...
|
|
WO/2010/074327A1 |
There is provided a halogen-containing organosulfur compound having a controlling effect on arthropod pests represented by the formula (I): wherein m represents 0, 1 or 2; n represents 0, 1 or 2; A represents an optionally substituted 3-...
|
|
WO/2010/075280A2 |
Compounds including those of the Formula I where X, R1, R2 and subscript t are as defined herein, useful as γ-secretase inhibitors, are provided, as are compositions comprising the compounds, as well as methods for use of the compounds ...
|
|
WO/2010/070910A1 |
Disclosed is a 1-heterodiene derivative represented by the formula (2); or, a salt thereof. In formula (2), W represents a hydrogen atom or the like; A, an oxygen atom or the like; R1, a C1-6 alkyl group or the like that is unsubstituted...
|
|
WO/2010/069758A1 |
A polymerizable photoinitiator represented by Formula (I): wherein R1, R2 and R3 are independently selected from the group consisting of a hydrogen, an optionally substituted alkyl group and an optionally substituted aryl group or R1 and...
|
|
WO/2010/069754A1 |
A UV radiation curable composition comprising a cationic photoinitiator according to Formula (I) or (II): wherein : R1, R2 and R3 independently represent a group selected from the group consisting of an aryl group and a heteroaryl group,...
|
|
WO/2010/067078A2 |
This invention pertains generally to processes, uses, methods and materials utilising particular xanthylium compounds, including compounds of formula (I) and (II), as further defined herein. These compounds are useful as drugs, for examp...
|
|
WO/2010/064632A1 |
Novel compounds which readily generate a base upon irradiation with long-wavelength light (actinic energy rays), a photo-base generator comprising any of these compounds, and a method of generating a base. The compounds are represented ...
|
|
WO/2010/063773A1 |
The present invention relates to novel 4- (heterocycloalkyl) benzene- 1, 3-diol compounds corresponding to general formula (I) below: to the compositions containing same, to the process for the preparation thereof and to the use thereof ...
|
|
WO/2010/056767A1 |
The present invention relates to novel compounds, methods, and compositions capable of decreasing HEF hydroxylase enzyme activity, thereby increasing the stability and/or activity of hypoxia inducible factor (HIF).
|
|
WO/2010/046194A1 |
Cyclohexanedione compounds, which are suitable for use as herbicides.
|
|
WO/2010/029017A1 |
A new type of polymerizable Norrish Type II photoinitiators having an optionally substituted benzophenone group or an optionally substituted thioxanthone group is disclosed exhibiting improved compatibility with and solubility in radiati...
|
|
WO/2010/019911A2 |
The present invention includes compositions and methods for inhibiting kinase activity to protect against neurodegeneration including diseases such as Alzheimer's disease, Parkinson's disease, or Huntington's disease, and conditions such...
|
|
WO/2010/016230A1 |
Disclosed is a benzoyl derivative represented by formula (I). [In formula (I), E represents an alkoxy group, an alkoxycarbonyl group or the like; R1 represents a halogen atom, an organic group or the like; p represents an integer of 0-3...
|
|
WO/2010/003976A1 |
The invention relates to novel heterocyclic compounds of the formula (I); in which all of the variables are as defined in the specification, in free form or in salt form, to their preparation, to their use as medicaments and to medicamen...
|
|
WO/2010/000773A1 |
Compounds of formula (I), wherein the substituents are as defined in claim 1, are suitable for use as herbicides.
|
|
WO/2009/150094A1 |
Pyranone, thiopyranone and cyclohexenedione compounds of formula (I), which are suitable for use as herbicides.
|
|
WO/2009/150095A1 |
Pesticidal compositions containing pyrandione, thiopyrandione and cyclohexanetrione compounds and methods of using them to combat and control pests such as insect, acarine, mollusc and nematode pests.
|
|
WO/2009/150093A1 |
Pyrandione, thiopyrandione and cyclohexanetrione derivatives of formula (I), which are suitable for use as herbicides.
|
|
WO/2009/136482A1 |
Disclosed is a phosphonium salt which has sufficient photosensitivity to an active energy ray such as visible light, ultraviolet ray, electron beam and X-ray. Specifically disclosed is a phosphonium salt represented by formula (1). In th...
|
|
WO/2009/129726A1 |
The present invention provides novel nitrones, their preparation and use. The novel compounds have the following formula: I The compounds of the present invention have strong antioxidative activity, and are thrombolytic. These compounds ...
|
|
WO/2009/123194A1 |
Disclosed is a compound which has an antagonistic activity on a melanin-concentrating hormone receptor and low toxicity and is useful as a prophylactic/therapeutic agent for obesity or the like. Specifically disclosed is a compound repre...
|
|
WO/2009/116883A2 |
A process for preparing the S or R enantiomer of a compound of formula A, (see formula (B) and formula (A)), the process comprising subjecting a compound of formula B to asymmetric hydrogenation in the presence of a chiral transition met...
|
|
WO/2009/116290A1 |
Provided are a 4-halogenobenzoyl derivative useful as the active ingredient of herbicides for paddy rice which can be industrially advantageously synthesized, ensures an efficacy in a lower dose and has a high safety; a salt thereof; and...
|
|
WO/2009/113322A1 |
Provided is a photodissociable protective group which can be eliminated from the protection site under mild conditions with light irradiation. Specifically, a method is provided which comprises using the photodissociable protective group...
|
|
WO/2009/077186A1 |
The present invention relates to nonsteriodal progesterone receptor modulators of the general formula 1, the use of the progesterone receptor modulators for producing medicaments and also pharmaceutical compositions containing these comp...
|
|
WO/2009/078078A1 |
Thiopyran derivatives that are useful in the increase of refractive index of resist substratum resin without detriment to the transparency and acid reactivity required for resist; polymers having the thiopyran derivatives as constituents...
|
|
WO/2009/074314A1 |
Pyrandione, thiopyrandione and cyclohexanetrione compounds, which are suitable for use as herbicides.
|
|
WO/2009/068590A1 |
An intermediate for preparing (meth)acrylated photoinitiators according to Formula (I): wherein: R1 is selected from the group consisting of hydrogen and a methyl group; A represents a group comprising at least one photoinitiating moiety...
|
|
WO/2009/060235A1 |
A photoinitiator compound and a method for preparing same is described. The photoinitiator compound is of formula O X A1 Q Y S O O x I wherein: X represents a halogen atom; Y represents an alkylyl or alkenylyl moiety; A1 represents a gro...
|
|
WO/2009/055516A1 |
The present invention is directed to a process, having a reduced environmental impact, for preparing phenylamino substituted quaternary salt compounds that are CCR2 antagonists.
|
|
WO/2009/055519A1 |
The present invention is directed to a process, having a reduced environmental impact, for preparing phenylamino substituted quaternary salt compounds that are CCR2 antagonists.
|
|
WO/2009/047568A2 |
Certain compounds of Formula (I) or salts thereof are suitable for use in the in vitro preservation of living animal cells. The living animal cells may be isolated cells, such as stem cells, or groups of cells such as tissue or an organ.
|
|
WO/2009/024615A1 |
The invention relates to novel heterocyclic compounds of the formula in which all of the variables are as defined in the specification, in free form or in salt form, to their preparation, to their use as medicaments and to medicaments co...
|
|
WO/2009/014100A1 |
Disclosed is a p27 protein inducer comprising a compound represented by the general formula (11) or a pharmaceutically acceptable salt thereof as an active ingredient. (11) wherein G1, G2, G3 and G8 are independently selected from -N= an...
|
|
WO/2008/155351A1 |
The invention relates to homocysteine analogue compounds and their use to prepare drugs for treating a disease selected from the group constituted by spina bifida, meningocele, autism, depression, schizophrenia, an extrapyramidal disease...
|
